Clinical Trial Update: PATCH 2&3:Prevention & Treatment of COVID-19 (Severe Acute Respiratory Syndrome Coronavirus 2) With Hydroxychloroquine [Phase 2]

View source ↗

Summary

Phase 2 trial update on hydroxychloroquine for prevention and treatment of COVID-19 (SARS-CoV-2) was terminated; results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronavirus Disease 2019

Drugs mentioned

• Hydroxychloroquine (hydroxychloroquine)

Snippet

Sponsor: UnitedHealth Group | Conditions: Coronavirus, Corona Virus Infection | Phase 2 | Status: TERMINATED | Results posted: 2021-10-19